New trials data could sway Medicare decision on ICDs (implantable cardioverter defibrillators)
This article was originally published in Clinica
Executive Summary
The Centers for Medicare & Medicaid Services (CMS) has decided to give the public an additional 30 days to comment on its pending decision on whether to expand coverage of implantable cardioverter defibrillators (ICDs) to additional patients deemed at risk of sudden cardiac death (SCD).